Acromegaly: Improving Timely Diagnosis, Assessment, and Treatment

Acromegaly: Improving Timely Diagnosis, Assessment, and Treatment is organized by EXCEL Continuing Education.

Dates:
May 01, 2023 through May 08, 2024

Description:
Acromegaly is a rare, chronic, progressive disease characterized by an excess secretion of growth hormone (GH) and increased circulating insulin-like growth factor 1 (IGF-1) concentrations. It is caused by a pituitary adenoma in most cases. The clinical diagnosis, based on symptoms related to GH excess, is often delayed due to the insidious nature of the disease. Consequently, patients often have established systemic complications at diagnosis with increased morbidity and premature mortality.

Educational Objectives:
• Identify key clinical findings and presenting symptoms of patients that may be at high risk for acromegaly
• Discuss effective diagnostic strategies that allow for earlier treatment selection while reviewing the consequences of a delayed diagnosis
• Describe the common comorbidities associated with acromegaly and the burden on patient QoL despite endocrine control
• Assess currently approved and emerging treatment options for managing patients with acromegaly